APICA (also known as SDB-001, and 2NE1) is a novel synthetic cannabinoid that produces modified cannabis-like effects when administered. It has been shown to act as a potent agonist for the CB1 and CB2 cannabinoid receptors.
APICA molecular structure diagram from the DrugsPRO substance library.
Also known as: SDB-001, 2NE1
Classification
Chemical: Cannabinoid
Chemical: Synthetic cannabinoid
Tag: Indole cannabinoid
Tag: Indolecarboxamide
Effects
Spontaneous Bodily Sensations
Vasodilation
Pain Relief
Dry Mouth
Sedation
Thought Connectivity
Mindfulness
Conceptual Thinking
Anxiety
Paranoia
Thought Deceleration
Auditory Distortion
Dehydration
Changes In Felt Gravity
Perception Of Bodily Heaviness
Increased Music Appreciation
Auditory Acuity Enhancement
Routes of Administration
Smoked
Dosage
Threshold: 0.5 mg
Heavy: 4 mg
Common: 1.5-2 mg
Light: 0.5-1.5 mg
Strong: 2-4 mg
Duration
Onset: 0 h
Peak: 0.2-0.5 h
Offset: 0.1-0.2 h
After Effects: 0.2-0.6 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
APICA - دليل المواد DrugsPRO
APICA: APICA (also known as SDB-001, and 2NE1) is a novel synthetic cannabinoid that produces modified cannabis-like effects when administered. It has been shown to act as a potent agonist for the CB1 and CB2 cannabinoid receptors.